# Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia

> **NCT00405171** · PHASE4 · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 40 (—)

## Conditions studied

- HIV Infections
- Hypercholesterolemia
- Antiretroviral Therapy

## Interventions

- **DRUG:** Nevirapine

## Key facts

- **NCT ID:** NCT00405171
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 40 (—)
- **Last updated:** 2010-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00405171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00405171, "Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00405171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*